What should patients verify about insurance coverage for Ozempic in 2026?

For Ozempic coverage in 2026, verify its place on your insurance formulary, its prior authorization rules, and your total out-of-pocket costs.

Confirm Ozempic's Status on Your 2026 Formulary

An insurance formulary is the list of prescription drugs covered by your plan. During the open enrollment period in late 2025, you must check the 2026 formulary to see if Ozempic is included. Insurers can and do change these lists annually.

Formularies are often divided into tiers. Generic drugs are typically in lower tiers (e.g., Tier 1) with low copays, while brand-name drugs like Ozempic are usually in higher tiers (e.g., Tier 3 or 4) with higher copays or coinsurance.

Check if Ozempic is listed as a 'preferred' or 'non-preferred' brand drug. A non-preferred status means your out-of-pocket cost will be significantly higher, and your plan may require you to try a preferred alternative first.

If Ozempic is not on the formulary at all, it will not be covered. In this case, you would be responsible for the full list price unless your physician can successfully appeal for a formulary exception, which is a difficult process.

Anticipate Prior Authorization and Step Therapy

Due to its high cost, most insurance plans require prior authorization (PA) for Ozempic. This means your physician must submit clinical documentation to the insurance company justifying why Ozempic is medically necessary for you.

The primary criterion for Ozempic approval is an FDA-approved diagnosis: improving glycemic control in adults with type 2 diabetes. Coverage is almost always denied for off-label use, such as weight loss without a diabetes diagnosis.

Many plans also enforce 'step therapy.' This policy requires you to first try and fail one or more less expensive, preferred medications for type 2 diabetes, such as metformin, before the plan will approve Ozempic. These requirements are expected to remain strict in 2026.

Work with your physician's office to ensure they have the necessary diagnostic codes and lab results to submit with the PA request. The approval process can take several days or weeks, so it is important to start early.

How the Inflation Reduction Act Affects Medicare Costs

For patients with Medicare Part D, the Inflation Reduction Act (IRA) introduces significant changes that will be in full effect by 2026. As of 2025, the law caps annual out-of-pocket drug costs for beneficiaries at $2,000.

This cap means that once a Medicare patient's spending on covered drugs (including Ozempic) reaches $2,000 for the year, they will have a $0 copay for the remainder of the year. This provides significant financial protection compared to previous plan structures.

The IRA also allows Medicare to negotiate prices for certain high-cost drugs. While Ozempic was not on the initial list for 2026 negotiation, it is a likely candidate for future rounds. If selected, its negotiated price could influence plan premiums and cost-sharing in later years.

Coverage is Tied to FDA-Approved Indications

It is crucial to understand that Ozempic is FDA-approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. It is also approved to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and known heart disease.

Insurance coverage is tied directly to these indications. Payers use diagnosis codes to verify that a prescription is for an approved use. Using Ozempic solely for chronic weight management is considered off-label, and insurers will not cover it.

The medication semaglutide is available under the brand name Wegovy, which is FDA-approved for chronic weight management. If your goal is medical support for weight loss, you and your doctor should pursue coverage for Wegovy, though coverage for anti-obesity medications can still be challenging.

As demand for GLP-1 medications continues to grow, expect insurers in 2026 to be even more stringent in enforcing indication-specific coverage to manage their costs.

Bottom Line: Your 2026 Ozempic Verification Checklist

As the 2026 plan year approaches, proactively verify coverage. During the 2025 open enrollment period, obtain the official formulary for any plan you consider and confirm Ozempic is on it and in what tier.

Contact the insurance provider directly to ask about prior authorization criteria and step therapy requirements for Ozempic. Ask for the specific clinical information your doctor will need to provide.

If you are a Medicare beneficiary, understand how the $2,000 out-of-pocket cap will apply to your costs. For all patients, calculate your potential expenses by considering your deductible, copay, or coinsurance.

If coverage is denied or unaffordable, you can check for patient assistance programs directly from the manufacturer, Novo Nordisk, which may offer the medication at a reduced cost or for free to eligible, uninsured, or underinsured individuals.

This information is for educational purposes only and does not constitute medical advice.

Generated from GOAL.MD's physician-reviewed source library. This page has not received its own physician review. Physician-supervised telehealth. More at goal.md/answers.